The global Gastrointestinal Drugs market size was estimated to be US$ 47 billion in 2021 and is expected grow at a CAGR of 6.1% between 2023 to 2032.Medicines for the gastrointestinal system are primarily intended to provide and treat digestive tract organs such as the liver, biliary tract, and pancreas and disorder.